Increased lipocalin-2 expression in pulmonary inflammation and fibrosis

被引:1
|
作者
Galaris, Apostolos [1 ]
Fanidis, Dionysios [1 ]
Tsitoura, Eliza [2 ]
Kanellopoulou, Paraskevi [1 ]
Barbayianni, Ilianna [1 ]
Ntatsoulis, Konstantinos [1 ]
Touloumi, Katerina [1 ]
Gramenoudi, Sofia [1 ]
Karampitsakos, Theodoros [3 ]
Tzouvelekis, Argyrios [3 ]
Antoniou, Katerina [2 ]
Aidinis, Vassilis [1 ]
机构
[1] Inst Fundamental Biomed Res, Biomed Sci Res Ctr Alexander Fleming, Athens, Greece
[2] Univ Crete, Sch Med, Dept Resp Med, Iraklion, Greece
[3] Univ Patras, Sch Med, Dept Resp Med, Patras, Greece
关键词
idiopathic pulmonary fibrosis (IPF); bleomycin (BLM); acute lung injury; transcriptomics; lipocalin-2 (LCN2); GELATINASE-ASSOCIATED LIPOCALIN; PROGRESSION; BIOMARKER;
D O I
10.3389/fmed.2023.1195501
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionIdiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive interstitial lung disease with dismal prognosis. The underlying pathogenic mechanisms are poorly understood, resulting in a lack of effective treatments. However, recurrent epithelial damage is considered critical for disease initiation and perpetuation, via the secretion of soluble factors that amplify inflammation and lead to fibroblast activation and exuberant deposition of ECM components. Lipocalin-2 (LCN2) is a neutrophil gelatinase-associated lipocalin (NGAL) that has been suggested as a biomarker of kidney damage. LCN2 has been reported to modulate innate immunity, including the recruitment of neutrophils, and to protect against bacterial infections by sequestering iron.MethodsIn silico analysis of publicly available transcriptomic datasets; ELISAs on human IPF patients' bronchoalveolar lavage fluids (BALFs); bleomycin (BLM)-induced pulmonary inflammation and fibrosis and LPS-induced acute lung injury (ALI) in mice: pulmonary function tests, histology, Q-RT-PCR, western blot, and FACS analysis.Results and discussionIncreased LCN2 mRNA expression was detected in the lung tissue of IPF patients negatively correlating with respiratory functions, as also shown for BALF LCN2 protein levels in a cohort of IPF patients. Increased Lcn2 expression was also detected upon BLM-induced pulmonary inflammation and fibrosis, especially at the acute phase correlating with neutrophilic infiltration, as well as upon LPS-induced ALI, an animal model characterized by neutrophilic infiltration. Surprisingly, and non withstanding the limitations of the study and the observed trends, Lcn2-/- mice were found to still develop BLM- or LPS-induced pulmonary inflammation and fibrosis, thus questioning a major pathogenic role for Lcn2 in mice. However, LCN2 qualifies as a surrogate biomarker of pulmonary inflammation and a possible indicator of compromised pulmonary functions, urging for larger studies.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] LIPOCALIN-2 IS AN ENDOGENOUS INHIBITOR OF INFLAMMATION IN MURINE NEPHROTOXIC SERUM NEPHRITIS
    Eller, Kathrin
    Schroll, Andrea
    Banas, Miriam
    Kirsch, Alexander
    Huber, Julia
    Weiss, Guenter
    Theurl, Igor
    Rosenkranz, Alexander R.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 443 - 443
  • [22] A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis
    Takahashi, T.
    Asano, Y.
    Noda, S.
    Aozasa, N.
    Akamata, K.
    Taniguchi, T.
    Ichimura, Y.
    Toyama, T.
    Sumida, H.
    Kuwano, Y.
    Tada, Y.
    Sugaya, M.
    Kadono, T.
    Sato, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (03) : 681 - 689
  • [23] A systematic review of the implications of lipocalin-2 expression in periodontal disease
    Solis-Suarez, Diana L.
    Cifuentes-Mendiola, Saul E.
    Garcia-Hernandez, Ana L.
    EVIDENCE-BASED DENTISTRY, 2024, : 69 - 69
  • [24] Lipocalin-2 expression modulates ferroptosis in pancreatic ductal adenocarcinoma
    Grisanti, Valentina Pita
    Dangel, Andrew W.
    Pietrzak, Maciej
    Hite, Amy
    Cruz-Monserrate, Zobeida
    CANCER RESEARCH, 2022, 82 (22) : 61 - 62
  • [25] The mRNA expression of visfatin and lipocalin-2 in peripheral blood mononuclear cells from patients with pulmonary tuberculosis
    Li, Hong-Miao
    Huang, Qian
    Chen, Shuang-Shuang
    Zhang, Gen-You
    Shi, Si-Jiu
    Wang, Hua
    Li, Ye
    Zhang, Tian-Ping
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (11)
  • [26] Lipocalin-2 and intestinal diseases
    Zhang, Zhong-Xu
    Peng, Jian
    Ding, Wei-Wei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (46)
  • [27] Lipocalin-2 and Cerebral Stroke
    Luo, Chao
    Zhou, Shuai
    Yin, Shi
    Jian, Lipeng
    Luo, Pengren
    Dong, Jigeng
    Liu, Erheng
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [28] Increased Urinary Lipocalin-2 Reflects Matrix Metalloproteinase-9 Activity in Chronic Hepatitis C with Hepatic Fibrosis
    Kim, Jin-Wook
    Lee, Sang Hyub
    Jeong, Sook-Hyang
    Kim, Haeryoung
    Ahn, Keun Soo
    Cho, Jai Young
    Yoon, Yoo-Seok
    Han, Ho-Seong
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 222 (04): : 319 - 327
  • [29] Plasma level of lipocalin-2 is increased in neovascular age-related macular degeneration, particularly in patients with macular fibrosis
    Yang, Nan
    Lechner, Judith
    Hogg, Ruth E.
    Toth, Levente
    Silvestri, Giuliana
    Chakravarthy, Usha
    Chen, Mei
    Xu, Heping
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [30] Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment
    Gomez-Chou, Sobeyda B.
    Swidnicka-Siergiejko, Agnieszka Katarzyna
    Badi, Niharika
    Chavez-Tomar, Myrriah
    Lesinski, Gregory B.
    Bekaii-Saab, Tanios
    Farren, Matthew R.
    Mace, Thomas A.
    Schmidt, Carl
    Liu, Yan
    Deng, Defeng
    Hwang, Rosa F.
    Zhou, Liran
    Moore, Todd
    Chatterjee, Deyali
    Wang, Huamin
    Leng, Xiaohong
    Arlinghaus, Ralph B.
    Logsdon, Craig D.
    Cruz-Monserrate, Zobeida
    CANCER RESEARCH, 2017, 77 (10) : 2647 - 2660